Renascience (TSE:4889) Other Current Receivables: 円10.74 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4889 Renascience Inc TSE:4889
51 GF Score
Price 円1,148.00
GF Value 円305.40
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Renascience Other Current Receivables?

Renascience TSE:4889 -6.67% 51 Other Current Receivables is 円10.74 Mil as of Mar. 2026. GuruFocus rates TSE:4889 with a GF Score™ of 51/100 and a GF Value™ of 円305.40 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Renascience's Other Current Receivables for the quarter that ended in Mar. 2026 was 円10.74 Mil.

Renascience's quarterly Other Current Receivables declined from Sep. 2025 (円4.90 Mil) to Dec. 2025 (円0.00 Mil) but then increased from Dec. 2025 (円0.00 Mil) to Mar. 2026 (円10.74 Mil).

Renascience's annual Other Current Receivables increased from Mar. 2024 (円0.06 Mil) to Mar. 2025 (円17.75 Mil) but then declined from Mar. 2025 (円17.75 Mil) to Mar. 2026 (円10.74 Mil).

Renascience Other Current Receivables Related Terms

Renascience Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Renascience's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renascience Other Current Receivables Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial 0.00 0.00 0.06 17.75 10.74

Renascience Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.90 4.90 0.00 10.74 0.00
TSE:4889
51GF Score
Renascience Inc TSE:4889
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Renascience Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of 円10.74 Mil mean?
Renascience (TSE:4889) has a Other Current Receivables of 円10.74 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Renascience and its competitors.
Is Renascience's Other Current Receivables too high?
Renascience's current Other Current Receivables is 円10.74 Mil. Overall, Renascience has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Renascience's Other Current Receivables compare to ABT and SYK?
Renascience's Other Current Receivables of 円10.74 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Renascience and its competitors. Renascience's current Other Current Receivables is 円10.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Renascience stock overvalued right now?
Based on GuruFocus' analysis, Renascience (TSE:4889) is currently considered Significantly Overvalued. The stock's GF Value™ is 円305.40, compared to a current price of 円1,148.00 — trading 275.9% above its estimated fair value. The current Other Current Receivables is 円10.74 Mil. Renascience's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Renascience (TSE:4889), the current Other Current Receivables is 円10.74 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Renascience (TSE:4889) Overvalued in 2026?

Based on GuruFocus' analysis, Renascience stock appears to be overvalued. The current stock price of 円1,148.00 is trading 275.9% above its estimated GF Value™ of 円305.40. GuruFocus considers Renascience to be Significantly Overvalued.

Key valuation signals for TSE:4889:

  • Other Current Receivables: 円10.74 Mil
  • GF Value™: 円305.40 vs. price of 円1,148.00 (275.9% above fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the TSE:4889 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Renascience Business Description

Address 2-1 Seiryo-cho, Aoba-ku, Miyagi, Sendai, JPN, 103-0023
Renascience Inc is engaged in the Development and commercialization of pharmaceuticals, medical devices, pieces of software as a medical device (SaMD) utilizing AI, etc.
51GF Score

Get the complete analysis for TSE:4889

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,148.00
Price
円305.40
GF Value